Perampanel in Seizure Patients With Primary Glial Brain Tumors

Clinical trial NCT02363933 · COMPLETED

Trial details

NCT number: NCT02363933
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Brain Tumor, Primary

Start date: 2015-04-07
Primary completion: 2017-03-14
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.